Premium Information is available for this item - Upgrade for $1 a day
6505-01-337-0319
Usp Ceftazidime For Injection
6505013370319 013370319 CEPTAZ NDC00173-0414-00
INC: 42844 Ceftazidime For Injection
January 2023
6
Marketplace 6505-01-337-0319
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-337-0319 5+ Documents (More...)
6505-01-337-0319 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-337-0319
/fsg-65/fsc-6505/us 6505-01-337-0319 /fsg-65/fsc-6505/us 6505-01-337-0319 Usp Ceftazidime For Injection
For Injection6505013370318 013370318 CEPTAZ CEPTAZ Ceftazidime For Injection6505013370318 013370318
Upgrade your Account Upgrade 6505-01-337-0319Usp Ceftazidime For Injection6505013370319 013370319 CEPTAZ
For Injection6505013370319 013370319 CEPTAZ 0319 Usp Ceftazidime For Injection 6505013370319 Ceftazidime
Upgrade your Account Upgrade 6505-01-336-6182Usp Ceftazidime For Injection6505013366182 013366182 CEPTAZ
Ceftazidime For Injection6505013366182 013366182 CEPTAZ 6505013002115 Ceftazidime For Injection 6505013370319
Usp Ceftazidime For Injection 6505013370319 Ceftazidime For Injection 6505013445259 Upgrade your
Usp Ceftazidime For Injection 6505013370319 Ceftazidime https//www.nsnlookup.com /fsg-65/fsc https
Administration (VA)VKU/I Contains 24 Ea00000000024EA NATO Stock Numbers Related to 6505-01-268-3578 6505-01-337-0319
Restrictions 6505-01-337-0319
6505-01-337-0319 is a Usp Ceftazidime For Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-337-0319
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-337-0319
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-337-0319
- Part Number
- Manufacturer
- Status
- NDC00173-0414-00
- Manufacturer
- 34006 - Glaxo Wellcome Inc (Active)
- Primary Buy
- Primary Buy
- CEPTAZ
- 34006 - Glaxo Wellcome Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-337-0319
- Characteristic
- Specifications
- FIIG
- Specifications
- A34300
- Active Medicament Medicinal Strength [AKJA]
- 1.000 Grams Ceftazidime, Anhydrous Equivalent
- Physical Form [AGXW]
- Powder
- Primary Container Type [CQCT]
- Vial
- Primary Container Content Quantity [CRLK]
- 1.000 Grams Of Active Ingredient
- Total Primary Container Quantity [CSCW]
- 25
- Features Provided [CBBL]
- Sterile
- Special Features [FEAT]
- With Hanging Device For Intermittent Intravenous Administration
Similar Supply Items to 6505-01-337-0319
Freight Information 6505-01-337-0319
6505-01-337-0319 has freight characteristics managed by the Bonneville Power Administration.. 6505-01-337-0319 has a variance between NMFC and UFC when transported by rail and the description should be consulted.